RE:RE:RE:Processors many never get the same vaulations as producers. I'd be stunned (and not in a good way) if there are talks ongoing....there would have been no reason (apart from a nut punch and the associated balance sheet impact) to have undergone the recent financing if someone wanted LABS bad enough.....
But really, the big boys have the money and the time to wait LABs out.
I'm quite happy that they're taking their time with a CEO. Means they're vetting appropriately IMO. But I've said before, if they unveil some Canadian middle-mgmt sales 'director' who at times has been associated with healthcare (like when s/he goes to the hospital), then we're in deep trouble.
At one point I would have laughed at someone who said a takeout at $5 would be ok.....at this point I'd take half of that and call it even.....pretty sure many would too....sad....
alleyesonme wrote: Who knows!?!? There's the possibility discussions could be taking place as we speak. Perhaps that's why they haven't bothered bringing on a new CEO. Labs is ripe for the picking at such a low valuation. Many company's willing to take advantage and what a deal even at 500 million!